Phaos Technology Holdings (Cayman) (POAS) Receivables - Net (2024 - 2025)
Phaos Technology Holdings (Cayman)'s (POAS) quarterly Receivables - Net came in at $36598.0 in Q4 2025, up 27.45% on a QoQ basis from $28715.2 in Q2 2025.
Phaos Technology Holdings (Cayman) (POAS) Receivables - Net (2024 - 2025) Analysis & Trends
Phaos Technology Holdings (Cayman) (POAS) has 2 years of Receivables - Net data on file, last reported at $36598.0 in Q4 2025.
- Quarterly Receivables - Net changed N/A year-over-year to $36598.0 in Q4 2025, while the trailing twelve-month figure through Oct 2025 was $36598.0 (changed N/A YoY) and the FY2025 annual result came in at $29402.0, down 90.92% from the prior year.
- Receivables - Net advanced to $36598.0 in Q4 2025, from $28715.2 in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $323867.8 in Q2 2024 to a low of $28715.2 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn |
| 10 | Phaos Technology Holdings (Cayman) | 4.25 Mn | 4.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | 36,598.00 |
| Oct 31, 2025 | 36,598.00 |
| Apr 30, 2025 | 28,715.19 |
| Apr 30, 2025 | 28,715.19 |
| Apr 30, 2024 | 323,867.81 |
| Apr 30, 2024 | 323,867.81 |